Literature DB >> 33632736

Widening the Neuroimaging Features of Adenosine Deaminase 2 Deficiency.

A F Geraldo1,2, R Caorsi3, D Tortora4, C Gandolfo5, R Ammendola1, M Alessio6, G Conti7, A Insalaco8, S Pastore9, S Martino10, I Ceccherini11, S Signa3, M Gattorno3, A Rossi1,12, M Severino1.   

Abstract

Adenosine deaminase 2 deficiency (OMIM #615688) is an autosomal recessive disorder characterized by a wide clinical spectrum, including small- and medium-sized vessel vasculopathies, but data focusing on the associated neuroimaging features are still scarce in the literature. Here, we describe the clinical neuroimaging features of 12 patients with genetically proven adenosine deaminase 2 deficiency (6 males; median age at disease onset, 1.3 years; median age at genetic diagnosis, 15.5 years). Our findings expand the neuroimaging phenotype of this condition demonstrating, in addition to multiple, recurrent brain lacunar ischemic and/or hemorrhagic strokes, spinal infarcts, and intracranial aneurysms, also cerebral microbleeds and a peculiar, likely inflammatory, perivascular tissue in the basal and peripontine cisterns. Together with early clinical onset, positive family history, inflammatory flares and systemic abnormalities, these findings should raise the suspicion of adenosine deaminase 2 deficiency, thus prompting genetic evaluation and institution of tumor necrosis factor inhibitors, with a potential great impact on neurologic outcome.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33632736      PMCID: PMC8115359          DOI: 10.3174/ajnr.A7019

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  22 in total

1.  Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.

Authors:  Sira Nanthapisal; Claire Murphy; Ebun Omoyinmi; Ying Hong; Ariane Standing; Stefan Berg; Maria Ekelund; Stephen Jolles; Lorraine Harper; Taryn Youngstein; Kimberly Gilmour; Nigel J Klein; Despina Eleftheriou; Paul A Brogan
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

2.  Anterior spinal artery aneurysm presenting with spinal subarachnoid hemorrhage in a case of polyarteritis nodosa.

Authors:  Garrett Smith; Brian L Hoh; Mehmet S Albayram
Journal:  Clin Imaging       Date:  2019-04-17       Impact factor: 1.605

3.  Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.

Authors:  Joris M Van Montfrans; Esther A R Hartman; Kees P J Braun; Eric A M Hennekam; Elisabeth A Hak; Paul J Nederkoorn; Willeke F Westendorp; Robbert G M Bredius; Wouter J W Kollen; Elisabeth H Schölvinck; G Elizabeth Legger; Isabelle Meyts; Adrian Liston; Klaske D Lichtenbelt; Jacques C Giltay; Gijs Van Haaften; Gaby M De Vries Simons; Helen Leavis; Cornelis J G Sanders; Marc B Bierings; Stefan Nierkens; Marielle E Van Gijn
Journal:  Rheumatology (Oxford)       Date:  2016-02-10       Impact factor: 7.580

4.  Deficiency of adenosine deaminase 2; special focus on central nervous system imaging.

Authors:  Elif Bulut; Abdulsamet Erden; Omer Karadag; Kader Karli Oguz; Seza Ozen
Journal:  J Neuroradiol       Date:  2018-06-18       Impact factor: 3.447

5.  Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency.

Authors:  Willeke F Westendorp; Paul J Nederkoorn; Ivona Aksentijevich; A Elisabeth Hak; Klaske D Lichtenbelt; Kees P J Braun
Journal:  Neurology       Date:  2015-04-17       Impact factor: 9.910

6.  Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

Authors:  Paulina Navon Elkan; Sarah B Pierce; Reeval Segel; Tom Walsh; Judith Barash; Shai Padeh; Abraham Zlotogorski; Yackov Berkun; Joseph J Press; Masha Mukamel; Isabel Voth; Philip J Hashkes; Liora Harel; Vered Hoffer; Eduard Ling; Fatos Yalcinkaya; Ozgur Kasapcopur; Ming K Lee; Rachel E Klevit; Paul Renbaum; Ariella Weinberg-Shukron; Elif F Sener; Barbara Schormair; Sharon Zeligson; Dina Marek-Yagel; Tim M Strom; Mordechai Shohat; Amihood Singer; Alan Rubinow; Elon Pras; Juliane Winkelmann; Mustafa Tekin; Yair Anikster; Mary-Claire King; Ephrat Levy-Lahad
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

7.  Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.

Authors:  Nisha Garg; Ozgur Kasapcopur; Joseph Foster; Kenan Barut; Ayşe Tekin; Osman Kızılkılıç; Mustafa Tekin
Journal:  Eur J Pediatr       Date:  2014-04-16       Impact factor: 3.183

8.  Ruptured intracranial aneurysms in pediatric polyarteritis nodosa: case report.

Authors:  Keisuke Toyoda; Keisuke Tsutsumi; Tomohito Hirao; Tomonori Ono; Hideaki Takahata; Keisuke Toda; Hiroshi Baba; Masahiro Ito; Masahiro Yonekura
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

Review 9.  Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.

Authors:  Sara Ganhão; Graça Barros Loureiro; Diana Rita Oliveira; Rúben Dos-Reis-Maia; Francisca Aguiar; Rita Quental; Carla Moura; João Luís Barreira; Mariana Rodrigues; Iva Brito
Journal:  Clin Rheumatol       Date:  2020-06-13       Impact factor: 2.980

Review 10.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

Authors:  Joanna M Wardlaw; Colin Smith; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

View more
  3 in total

Review 1.  Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).

Authors:  Pui Y Lee; Ivona Aksentijevich; Qing Zhou
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 9.623

Review 2.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

3.  The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.

Authors:  Karyl S Barron; Ivona Aksentijevich; Natalie T Deuitch; Deborah L Stone; Patrycja Hoffmann; Ryan Videgar-Laird; Ariane Soldatos; Jenna Bergerson; Camilo Toro; Cornelia Cudrici; Michele Nehrebecky; Tina Romeo; Anne Jones; Manfred Boehm; Jennifer A Kanakry; Dimana Dimitrova; Katherine R Calvo; Hawwa Alao; Devika Kapuria; Gil Ben-Yakov; Dominique C Pichard; Londa Hathaway; Alessandra Brofferio; Elisa McRae; Natalia Sampaio Moura; Oskar Schnappauf; Sofia Rosenzweig; Theo Heller; Edward W Cowen; Daniel L Kastner; Amanda K Ombrello
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.